Delivery Order HHSN272201500006I-HHSN27200005
Award Date
3/15/17
Potential Completion Date
9/7/22
Potential Value
$1.1M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Duke University
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,361,452.65 federal contract award to Duke University, a private non-profit university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for a Phase 1 Clinical Trial Unit to develop therapeutics against infectious diseases. It is a delivery order placed under the Therapeutics Against Infectious Diseases Phase 1 indefinite delivery, indefinite quantity (IDIQ) contract. The contract has no...
This federal contract award is for a $109,969 Phase 1 Clinical Trial to be conducted by Duke University Office of Research Administration Division for the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The contract is a delivery order against the parent Therapeutics Against Infectious Diseases Phase 1 multiple-award IDIQ contract. Duke University, a private non-profit research university, is the prime...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $115,139.00 delivery order contract to Duke University Office Of Research Administration Division, a private non-profit educational institution, to support a Phase 1 clinical trial unit for therapeutics against infectious diseases. The contract is part of the Therapeutics Against Infectious Diseases Phase 1 master contract vehicle and has a completion date...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $136,864.00 delivery order contract to Duke University for Phase 1 clinical trial unit services to support Therapeutics Against Infectious Diseases research. The contract is not set aside and is part of a master Indefinite Delivery Indefinite Quantity (IDIQ) contract focused on therapeutics against infectious diseases. As the prime contractor, Duke...
This is a cost-no-fee Delivery Order contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to Duke University for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The contract has a ceiling value of $416,539.69 and a period of performance through August 31, 2017. This order is part of a larger Therapeutics Against Infectious Diseases Phase 1 Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. No set-aside...
This is a cost-plus-fixed-fee delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Duke University for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The potential value of the award is $126,086.19. The order was issued against the Therapeutics Against Infectious Diseases Phase 1 master contract. No set-aside designation was used. As the prime contractor, Duke University will provide clinical...
This is a task order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University. The task order is under the Early Phase Clinical Trial Units (EPCTU) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The award is for $1,963,927.00 and does not have a set-aside designation. The contract is for a cost-no-fee delivery order, with a period of performance extending to January 13, 2032. Duke University, a private...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,281,164 cost-no-fee delivery order to Duke University's Office of Research Administration Division to conduct a Phase 1 clinical trial on therapeutics against infectious diseases. The order is part of a larger Therapeutics Against Infectious Diseases Phase 1 contract. No set-aside designation was used. Duke University is a private research university...
This is a federal contract award to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract, valued at $10,236,804.91, is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract does not have a set-aside designation. The contract is described as "TAS::75 0885::TAS", which likely refers to the task or service area, though the specific details are not provided. The...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $99,299 cost-plus-fixed-fee delivery order was placed under the Therapeutics Against Infectious Diseases Phase 1 IDIQ contract, which funds Phase I clinical trials for therapeutic products targeting infectious diseases. The prime contractor is Dynport Vaccine Company LLC, a subsidiary of General Dynamics...